1. Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines. (December 2017) Authors: Lutz, Johannes; Lazzaro, Sandra; Habbeddine, Mohamed; Schmidt, Kim; Baumhof, Patrick; Mui, Barbara; Tam, Ying; Madden, Thomas; Hope, Michael; Heidenreich, Regina; Fotin-Mleczek, Mariola Journal: Npj vaccines Issue: Volume 2(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗